《Table 2 Status of Treponema pallidum A2058G and A2059G mutations in azithromycin-or BPG-treated pat

《Table 2 Status of Treponema pallidum A2058G and A2059G mutations in azithromycin-or BPG-treated pat   提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《Relationship between the high frequency of 23S rRNA point mutations in Treponema pallidum and low serological response rate to azithromycin treatment in China》


  1. 获取 高清版本忘记账户?点击这里登录
  1. 下载图表忘记账户?点击这里登录
Chi-squared tests were conducted,and P-values of<0.05 wereconsidered to indicate statistical significance.BPG,benzathinepenicillin G.

The A2058G and A2059G mutation statuses in the azithromycin and BPG groups are shown in Table 2.Of the 89 DNA samples obtained from the azithromycin group that were positive for the tpp47 gene,83(93.3%)were positive for a mutation,including 71(79.8%)positive for A2058G and 12(20.2%)positive for A2059G.Of these 83 samples,51(61.4%)were collected from chancres and 32 from condyloma lata and mucosal lesions.Of the 98 equivalent samples obtained from the BPG group,89(90.8%)were positive for one of the two mutations;82(83.7%)of these 89 patients had an A2058G mutation,and 7(7.1%)had an A2059G mutation.There was no significant difference in the proportions of the two mutations between the azithromycin and BPG groups(P>0.05).